Century Therapeutics, Inc. (IPSC) stock
IPSCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.64−0.01 (-0.61%)
Close on Nov 16, 2026Market cap $296.96MP/E –Yield –
Century Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Century Therapeutics's total debt was $10.30M at Mar 31, 2023. For fiscal 2022 it was $10.24M, up 3.0% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $10.24M | +3.0% |
| FY2021 | Dec 31, 2021 | $9.94M | +3.2% |
| FY2020 | Dec 31, 2020 | $9.64M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2023 | Mar 31, 2023 | $10.30M | +2.8% |
| Q4 FY2022 | Dec 31, 2022 | $10.24M | +3.0% |
| Q3 FY2022 | Sep 30, 2022 | $10.17M | +5.6% |
| Q2 FY2022 | Jun 30, 2022 | $10.10M | – |
| Q1 FY2022 | Mar 31, 2022 | $10.02M | – |
| Q4 FY2021 | Dec 31, 2021 | $9.94M | – |
| Q4 FY2020 | Dec 31, 2020 | $9.64M | – |
See a number that looks wrong?